| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.20B | 57.27B | 25.58B | 19.23B | 18.73B | 43.13B |
| Gross Profit | 23.20B | 57.27B | 27.40B | 20.35B | 19.66B | 33.69B |
| EBITDA | 5.17B | 5.42B | 5.11B | 3.22B | 2.91B | 2.67B |
| Net Income | 2.26B | 2.48B | 1.98B | 1.58B | 706.00M | 1.01B |
Balance Sheet | ||||||
| Total Assets | 177.29B | 193.71B | 180.42B | 168.53B | 193.13B | 197.52B |
| Cash, Cash Equivalents and Short-Term Investments | 120.02B | 5.26B | 123.34B | 5.10B | 95.53B | 106.21B |
| Total Debt | 7.84B | 8.48B | 8.90B | 9.11B | 9.78B | 7.73B |
| Total Liabilities | 159.04B | 172.82B | 161.92B | 151.73B | 180.54B | 179.58B |
| Stockholders Equity | 11.85B | 13.47B | 11.66B | 10.45B | 8.64B | 10.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.92B | 8.43B | 7.63B | 5.77B | 8.38B |
| Operating Cash Flow | 0.00 | 8.37B | 8.43B | 8.10B | 5.97B | 10.05B |
| Investing Cash Flow | 0.00 | -5.76B | -6.79B | -5.03B | -6.86B | -10.06B |
| Financing Cash Flow | 0.00 | -2.02B | -1.58B | -1.49B | 521.00M | 428.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €29.53B | 11.85 | 19.71% | 2.37% | 3.70% | 24.02% | |
74 Outperform | €32.89B | 12.16 | 21.53% | 3.37% | 2.57% | 9.75% | |
74 Outperform | €71.78B | 11.92 | 18.94% | 3.56% | 0.48% | 11.17% | |
71 Outperform | €142.88B | 13.65 | 17.77% | 3.94% | 25.33% | 12.54% | |
65 Neutral | €1.38B | 3.11 | -0.98% | 0.12% | -1.28% | -153.13% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | €1.38B | 11.26 | 2.43% | 4.49% | 4.19% | -75.44% |